Markus Puhlmann

Directeur Technique/Scientifique/R&D chez PERSPECTIVE THERAPEUTICS, INC.

Fortune : 2 M $ au 31/05/2024

Health Technology

Consumer Services

Postes actifs de Markus Puhlmann

Sociétés	Poste	Début	Fin
PERSPECTIVE THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	-	-

Sociétés	Poste	Début	Fin
SEAGEN INC.	Corporate Officer/Principal	01/01/2019	01/01/2022
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2015	01/01/2019

Ludwig-Maximilians-Universität München	Doctorate Degree
McDonough School of Business	Masters Business Admin

Internationale

Etats-Unis	5
Allemagne	2

Opérationnelle

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sectorielle

Health Technology	4
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
PERSPECTIVE THERAPEUTICS, INC.	Health Technology
MERCK & CO., INC.	Health Technology

Entreprise privées	1
Seagen Inc. Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.	Health Technology

Entreprise privées

Health Technology